A detailed history of Ronald Blue Trust, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 754 shares of ACAD stock, worth $11,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares
754
Previous 343 119.83%
Holding current value
$11,151
Previous $5,000 120.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$15.14 - $19.14 $6,222 - $7,866
411 Added 119.83%
754 $11,000
Q2 2024

Jul 18, 2024

BUY
$14.62 - $18.42 $5,014 - $6,318
343 New
343 $5,000
Q4 2023

Jan 18, 2024

BUY
$20.78 - $31.77 $3,220 - $4,924
155 New
155 $3,000
Q4 2022

Jan 17, 2023

BUY
$14.2 - $18.63 $42 - $55
3 Added 5.77%
55 $1,000
Q3 2022

Oct 21, 2022

BUY
$14.11 - $18.27 $564 - $730
40 Added 333.33%
52 $1,000
Q2 2022

Aug 09, 2022

BUY
$13.01 - $27.22 $156 - $326
12 New
12 $0

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.